IL104055A - Ethanol adducts of optically active 4r, 3s 6-sulfonyl 3-hydroxychromans and their use as inhalants in diseases - Google Patents
Ethanol adducts of optically active 4r, 3s 6-sulfonyl 3-hydroxychromans and their use as inhalants in diseasesInfo
- Publication number
- IL104055A IL104055A IL104055A IL10405592A IL104055A IL 104055 A IL104055 A IL 104055A IL 104055 A IL104055 A IL 104055A IL 10405592 A IL10405592 A IL 10405592A IL 104055 A IL104055 A IL 104055A
- Authority
- IL
- Israel
- Prior art keywords
- ethanol
- dimethyl
- hydroxy
- optically active
- inhalants
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4141350 | 1991-12-14 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL104055A0 IL104055A0 (en) | 1993-05-13 |
| IL104055A true IL104055A (en) | 1998-04-05 |
Family
ID=6447111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL104055A IL104055A (en) | 1991-12-14 | 1992-12-10 | Ethanol adducts of optically active 4r, 3s 6-sulfonyl 3-hydroxychromans and their use as inhalants in diseases |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US5310753A (fi) |
| EP (1) | EP0547523B1 (fi) |
| JP (1) | JP2625071B2 (fi) |
| CN (1) | CN1073172A (fi) |
| AT (1) | ATE122674T1 (fi) |
| AU (1) | AU653874B2 (fi) |
| CA (1) | CA2085166A1 (fi) |
| DE (1) | DE59202242D1 (fi) |
| DK (1) | DK0547523T3 (fi) |
| ES (1) | ES2073850T3 (fi) |
| FI (1) | FI925618A (fi) |
| HU (2) | HUT67172A (fi) |
| IL (1) | IL104055A (fi) |
| MX (1) | MX9207216A (fi) |
| NO (1) | NO300893B1 (fi) |
| NZ (1) | NZ245447A (fi) |
| RU (1) | RU2102391C1 (fi) |
| TW (1) | TW244350B (fi) |
| ZA (1) | ZA929616B (fi) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9316111D0 (en) * | 1993-08-04 | 1993-09-22 | Pfizer Ltd | Benzopyrans |
| DE4425255A1 (de) | 1994-07-16 | 1996-01-18 | Asta Medica Ag | Formulierung zur inhalativen Applikation |
| GB9510477D0 (en) * | 1995-05-24 | 1995-07-19 | Sandoz Ltd | Organic compounds |
| FR2756284B1 (fr) * | 1996-11-26 | 2000-04-28 | Adir | Nouveaux derives du benzopyrane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| US7306789B2 (en) | 2002-11-12 | 2007-12-11 | Warner-Lambert Company, Llc | Method of stimulating hair growth using benzopyrans |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8419515D0 (en) * | 1984-07-31 | 1984-09-05 | Beecham Group Plc | Treatment |
| GB8432063D0 (en) * | 1984-12-19 | 1985-01-30 | Riker Laboratories Inc | Physically modified steroids |
| DE3703227A1 (de) * | 1987-02-04 | 1988-08-18 | Hoechst Ag | Substituierte 3,4-dihydro-2h-benzopyrane, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen |
| DE3818245A1 (de) * | 1988-05-28 | 1989-12-07 | Hoechst Ag | Kombination von angiotensin-converting-enzyme-hemmern mit kaliumkanal-modulatoren sowie deren verwendung in arzneimitteln |
| FR2633605B1 (fr) * | 1988-07-01 | 1991-07-12 | Rhone Poulenc Chimie | Procede de preparation d'oxyde de titane et d'articles a base d'oxyde de titane |
| DE3824446A1 (de) * | 1988-07-19 | 1990-01-25 | Hoechst Ag, 6230 Frankfurt | Verwendung substituierter 3,4-dihydro-2h-benzopyrane als heilmittel gegen obstruktive funktionsstoerungen der lunge und/oder stoerungen der ableitenden harnwege |
| GB8918298D0 (en) * | 1989-08-10 | 1989-09-20 | Beecham Group Plc | Novel compounds |
-
1992
- 1992-11-27 TW TW081109501A patent/TW244350B/zh active
- 1992-12-10 US US07/988,839 patent/US5310753A/en not_active Expired - Fee Related
- 1992-12-10 FI FI925618A patent/FI925618A/fi unknown
- 1992-12-10 IL IL104055A patent/IL104055A/en not_active IP Right Cessation
- 1992-12-11 CA CA002085166A patent/CA2085166A1/en not_active Abandoned
- 1992-12-11 NO NO924806A patent/NO300893B1/no unknown
- 1992-12-11 JP JP4331334A patent/JP2625071B2/ja not_active Expired - Lifetime
- 1992-12-11 NZ NZ245447A patent/NZ245447A/en unknown
- 1992-12-11 EP EP92121155A patent/EP0547523B1/de not_active Expired - Lifetime
- 1992-12-11 ZA ZA929616A patent/ZA929616B/xx unknown
- 1992-12-11 ES ES92121155T patent/ES2073850T3/es not_active Expired - Lifetime
- 1992-12-11 DK DK92121155.3T patent/DK0547523T3/da active
- 1992-12-11 HU HU9203928A patent/HUT67172A/hu unknown
- 1992-12-11 AU AU30171/92A patent/AU653874B2/en not_active Ceased
- 1992-12-11 MX MX9207216A patent/MX9207216A/es not_active IP Right Cessation
- 1992-12-11 AT AT92121155T patent/ATE122674T1/de active
- 1992-12-11 DE DE59202242T patent/DE59202242D1/de not_active Expired - Fee Related
- 1992-12-14 CN CN92114177A patent/CN1073172A/zh active Pending
- 1992-12-14 HU HU9203928A patent/HU9203928D0/hu unknown
- 1992-12-14 RU RU92004582A patent/RU2102391C1/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| MX9207216A (es) | 1993-06-01 |
| DK0547523T3 (da) | 1995-09-11 |
| DE59202242D1 (de) | 1995-06-22 |
| AU653874B2 (en) | 1994-10-13 |
| CA2085166A1 (en) | 1993-06-15 |
| FI925618A0 (fi) | 1992-12-10 |
| AU3017192A (en) | 1993-06-17 |
| NO924806L (no) | 1993-06-15 |
| NO300893B1 (no) | 1997-08-11 |
| TW244350B (fi) | 1995-04-01 |
| US5310753A (en) | 1994-05-10 |
| NZ245447A (en) | 1994-09-27 |
| HU9203928D0 (en) | 1993-03-29 |
| ES2073850T3 (es) | 1995-08-16 |
| FI925618A (fi) | 1993-06-15 |
| JP2625071B2 (ja) | 1997-06-25 |
| HUT67172A (en) | 1995-02-28 |
| IL104055A0 (en) | 1993-05-13 |
| NO924806D0 (no) | 1992-12-11 |
| JPH05255303A (ja) | 1993-10-05 |
| ATE122674T1 (de) | 1995-06-15 |
| RU2102391C1 (ru) | 1998-01-20 |
| ZA929616B (en) | 1993-06-18 |
| EP0547523B1 (de) | 1995-05-17 |
| EP0547523A1 (de) | 1993-06-23 |
| CN1073172A (zh) | 1993-06-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7910573B2 (en) | Crystalline forms of 11β-(4-acetylphenyl)-20,20,21,21,21-pentafluoro-17-hydroxy-19-nor-17α-pregna-4,9-dien-3-one | |
| US20090197907A1 (en) | Novel crystalline form of rupatadine free base | |
| TW458970B (en) | Benzoylpyridazines having the activity in inhibiting phosphodiesterase IV | |
| EP1711477A1 (en) | Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1 | |
| US5310753A (en) | Ethanol adducts of 6-sulfonyl-substituted 3-hydroxy-chromans and their use as inhalants in diseases | |
| JPS62228057A (ja) | 化学化合物 | |
| JPH05221980A (ja) | アセチレン化合物 | |
| CA2260065C (en) | Process for preparing 1-substituted 4-cyano-1,2,3-triazoles | |
| EP2057144A2 (en) | Novel polymorphs of rimonabant | |
| IL100266A (en) | Imidazolyl-triazolyl- or tetrazolyl-A compounds Fluoromethylbenzene and their salts are aromatase inhibitors, a process for their preparation and pharmaceutical preparations containing them | |
| AU650569B2 (en) | Imidazol-1-yl methyl pyridine derivatives, processes for their production and their use as pharmaceuticals | |
| WO2011055233A2 (en) | Improved process for preparing celecoxib polymorph | |
| EP0531078A1 (en) | (R)-3-Methoxy-4- 1-methyl-5-(2-methyl-4,4,4-trifluorobutylcarbamoyl)indol-3-ylmethyl -N-(2-methylsulphonyl)benzamide in crystalline form | |
| DK155736B (da) | Analogifremgangsmaade til fremstilling af 4-(1-imidazolylmethyl)kanelsyre-hydrochlorid-monohydrat | |
| EP1925616A1 (en) | Process for the preparation of crystal forms of cabergoline via stable solvates of cabergoline | |
| CZ298518B6 (cs) | Zpusob cištení Lorazepamu | |
| WO2002060440A1 (en) | Novel forms of 2,3-dimethyl-8-(2-ethyl-6-methylbenzylamino)-imidazo (1,2-a)pyridine-6-carboxamide | |
| JPH06199809A (ja) | ２，５−ジブロモピリミジンの製造法 | |
| WO2004087682A1 (en) | Novel crystalline forms of parecoxib sodium | |
| WO2024209392A1 (en) | Process for preparing pralsetinib in amorphous form | |
| JPH0324047A (ja) | フェニルマロン酸モノアニリド誘導体および３―フェニル―２―キノロン誘導体の製造方法 | |
| JPH01213271A (ja) | 新規化学的方法 | |
| JPS5865296A (ja) | 抗菌性化合物及びその組成物 | |
| JP2011500804A (ja) | グルココルチコイド受容体リガンドの製造方法 | |
| IL195650A (en) | Crystalline forms of 11beta-(4-acetylphenyl)-20,2021,21,21-pentafluoro-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-one |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| RH | Patent void |